These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22627902)

  • 41. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
    Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estimation of HIV-1 Incidence Using a Testing History-Based Method; Analysis From the Population-Based HIV Impact Assessment Survey Data in 12 African Countries.
    Gurley SA; Stupp PW; Fellows IE; Parekh BS; Young PW; Shiraishi RW; Sullivan PS; Voetsch AC
    J Acquir Immune Defic Syndr; 2023 Mar; 92(3):189-196. PubMed ID: 36730779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody avidity-based approach to estimate population-level incidence of hepatitis C.
    Boon D; Bruce V; Patel EU; Quinn J; Srikrishnan AK; Shanmugam S; Iqbal S; Balakrishnan P; Sievers M; Kirk GD; Thomas DL; Quinn TC; Cox AL; Page KA; Solomon SS; Mehta SH; Laeyendecker O
    J Hepatol; 2020 Aug; 73(2):294-302. PubMed ID: 32240715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis.
    Bärnighausen T; McWalter TA; Rosner Z; Newell ML; Welte A
    Epidemiology; 2010 Sep; 21(5):685-97. PubMed ID: 20699682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Augmented cross-sectional prevalence testing for estimating HIV incidence.
    Wang R; Lagakos SW
    Biometrics; 2010 Sep; 66(3):864-74. PubMed ID: 19912174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-Sectional HIV Incidence Surveillance: A Benchmarking of Approaches for Estimating the 'Mean Duration of Recent Infection'.
    Kassanjee R; De Angelis D; Farah M; Hanson D; Labuschagne JPL; Laeyendecker O; Le Vu S; Tom B; Wang R; Welte A
    Stat Commun Infect Dis; 2017 Mar; 9(1):. PubMed ID: 29527254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Computational analysis of antibody dynamics identifies recent HIV-1 infection.
    Seaton KE; Vandergrift NA; Deal AW; Rountree W; Bainbridge J; Grebe E; Anderson DA; Sawant S; Shen X; Yates NL; Denny TN; Liao HX; Haynes BF; Robb ML; Parkin N; Santos BR; Garrett N; Price MA; Naniche D; Duerr AC; ; Keating S; Hampton D; Facente S; Marson K; Welte A; Pilcher CD; Cohen MS; Tomaras GD
    JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimating the expectation of the log-likelihood with censored data for estimator selection.
    Liquet B; Commenges D
    Lifetime Data Anal; 2004 Dec; 10(4):351-67. PubMed ID: 15690990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Collaborative targeted maximum likelihood for time to event data.
    Stitelman OM; van der Laan MJ
    Int J Biostat; 2010; 6(1):Article 21. PubMed ID: 21969976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparing Parametric, Nonparametric, and Semiparametric Estimators: The Weibull Trials.
    Cole SR; Edwards JK; Breskin A; Hudgens MG
    Am J Epidemiol; 2021 Aug; 190(8):1643-1651. PubMed ID: 33569578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence estimation when disease status is verified only among test positives: Applications in HIV screening programs.
    G Thomas E; B Peskoe S; Spiegelman D
    Stat Med; 2018 Mar; 37(7):1101-1114. PubMed ID: 29230839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parametric likelihood inference for interval censored competing risks data.
    Hudgens MG; Li C; Fine JP
    Biometrics; 2014 Mar; 70(1):1-9. PubMed ID: 24400873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.
    Facente SN; Grebe E; Maher AD; Fox D; Scheer S; Mahy M; Dalal S; Lowrance D; Marsh K
    JMIR Public Health Surveill; 2022 Mar; 8(3):e34410. PubMed ID: 35275085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Notes on interval estimation of the attributable risk in cross-sectional sampling.
    Lui KJ
    Stat Med; 2001 Jun; 20(12):1797-809. PubMed ID: 11406842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards.
    Park SY; Love TMT; Reynell L; Yu C; Kang TM; Anastos K; DeHovitz J; Liu C; Kober KM; Cohen M; Mack WJ; Lee HY
    Sci Rep; 2017 Aug; 7(1):7480. PubMed ID: 28785052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimation of incidence of HIV infection using cross-sectional marker surveys.
    Statten GA; Longini IM
    Biometrics; 1994 Sep; 50(3):675-88. PubMed ID: 7981394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence.
    Keating SM; Kassanjee R; Lebedeva M; Facente SN; MacArthur JC; Grebe E; Murphy G; Welte A; Martin JN; Little S; Price MA; Kallas EG; Busch MP; Pilcher CD
    J Acquir Immune Defic Syndr; 2016 Dec; 73(5):581-588. PubMed ID: 27509247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using tests for recent infection to estimate incidence: problems and prospects for HIV.
    Welte A; McWalter TA; Laeyendecker O; Hallett TB
    Euro Surveill; 2010 Jun; 15(24):. PubMed ID: 20576235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HIV incidence estimate combining HIV/AIDS surveillance, testing history information and HIV test to identify recent infections in Lazio, Italy.
    Mammone A; Pezzotti P; Angeletti C; Orchi N; Carboni A; Navarra A; Sciarrone MR; Sias C; Puro V; Guasticchi G; Ippolito G; Borgia P; Girardi E;
    BMC Infect Dis; 2012 Mar; 12():65. PubMed ID: 22433313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection.
    Verhofstede C; Fransen K; Van Den Heuvel A; Van Laethem K; Ruelle J; Vancutsem E; Stoffels K; Van den Wijngaert S; Delforge ML; Vaira D; Hebberecht L; Schauvliege M; Mortier V; Dauwe K; Callens S
    BMC Infect Dis; 2017 Nov; 17(1):738. PubMed ID: 29187159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.